Unexplained or debilitating fatigue
Florenzano P, Ferreira C, Nesterova G, Roberts MS, Tella SH, de Castro LF, Brown SM, Whitaker A, Pereira RC, Bulas D, Gafni RI, Salusky IB, Gahl WA, Collins MT (2018) Skeletal consequences of nephropathic cystinosis
Safety Considerations and Who Should Start at .25 mg The .25 mg dose is standard for treatment initiation across all populations due to its favorable gastrointestinal tolerability profile
For best results, it is recommended to take 1 capsule 1 hour before sleeping, thus ensuring that the active ingredients work effectively while you rest
[16] DPP-4 inhibitors (such as sitagliptin), which enhance incretin activity through a different mechanism Insulin therapy, particularly if oral agents and other injectables are unsuitable Traditional agents like metformin, sulphonylureas, or pioglitazone, depending on individual circumstances NICE guideline NG28 recommends individualised treatment approaches based on HbA1c targets, cardiovascular risk, renal function, and patient preferences